The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects

Keyphrases

• Control Subjects 100%
• Healthy Controls 100%
• Age-related Macular Degeneration 100%
• Primary Open-angle Glaucoma 100%
• Ocular Blood Flow 100%
• Age-matched 66%
• Optic Nerve Head Blood Flow 66%
• Choroidal Blood Flow 66%
• Disease-associated 33%
• No Significant Difference 33%
• Blood Flow 33%
• Hypoperfusion 33%
• Blood Flow Velocity 33%
• Long-term Treatment 33%
• Systemic Administration 33%
• Retinal Vessels 33%
• Phosphodiesterase Inhibitors 33%
• Laser Doppler Velocimetry 33%
• Drug Administration 33%
• Retinal Blood Flow 33%
• Eye Diseases 33%
• Young Healthy Subjects 33%
• Laser Doppler Flowmetry 33%
• Optic Nerve Head 33%
• Dynamic Retinal Vessel Analysis 33%
• Retinal Vessel Diameter 33%
• Ciliary Artery 33%
• Mean Flow Velocity 33%
• Ocular Diseases 33%
• Choroidal 33%
• Ophthalmic Artery 33%
• Color Doppler Imaging 33%
• Retrobulbar 33%
• Elderly Patients 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Age Related Macular Degeneration 100%
• Open Angle Glaucoma 100%
• Moxaverine 100%
• Eye Disease 25%
• Systemic Administration 12%
• Normal Human 12%
• Agents Acting on the Eye 12%
• Phosphodiesterase Inhibitor 12%
• Drug Administration 12%

Neuroscience

• Phosphodiesterase Inhibitor 33%